Please login to the form below

Not currently logged in
Email:
Password:

Zydelig

This page shows the latest Zydelig news and features for those working in and with pharma, biotech and healthcare.

AZ’s Calquence threatens Imbruvica with new leukaemia data

AZ’s Calquence threatens Imbruvica with new leukaemia data

The ASCEND study pitted Calquence against Roche’s Rituxan (rituximab) combined with either Gilead’s Zydelig (idelalisib) or bendamustine, and will be used to support regulatory filings later this year along

Latest news

More from news
Approximately 9 fully matching, plus 20 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....